SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

NOVITA HEALTHCARE LIMITED (NHL)

Listed on ASX ( $        )

Former (or subsequent) names

 FROMTO
NOVITA HEALTHCARE LIMITED12/12/2016
AVEXA LIMITED12/12/2016

Shareholder links

 

REGISTRY:

Automic Registry Services Level 5 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 9698 5414
Fax : +61 8 9321 2337
RegistryWebsite RegistryEmail

Company details

Address: Suite G02, 1 Crescent Road, Glen Iris VIC 3146
Tel:  (03) 9208 4300 Fax: (03) 9208 4146

Date first listed: 23/09/2004
Company Secretary: John Osborne
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Avexa is a Melbourne-based medical technology company Its flagship program is the revolutionary and innovative TALI system, which uses cutting edge technology to diagnose and treat cognitive problems such as attention difficulties in early childhood
The suspension of trading in the securities of Novita Healthcare Limited will be lifted immediately, following the release by the Company of an announcement regarding a capital raising.20/07/2018
The company releases an Appendix 3B and a cleansing notice for the issue of 89,861,033 new shares at $0.031 per share to be allotted to professional and sophisticated investors on 25 July 2018. The company also gives out information pursuant to ASX Listing Rule 3.10.5A.20/07/2018
The company announces the successful $2.78 million placement at $0.031 per share to fund the commercialisation and growth of TALI. Novita has entered into a heads of agreement to sell Newly to HealthcareLink. The strategy is focused on delivering marketing leading digital screening tools and therapeutics.20/07/2018
The securities of Novita Healthcare Limited will be suspended from quotation immediately, in accordance with Listing Rule 17.3. The securities will remain suspended until the release of an announcement by the Company in relation to a capital raising.19/07/2018
name changed from Avexa Limited12/12/2016

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    08/10/2018Glenn Smith200,000 $0.032$6,400
    20/09/2018Jefferson Harcourt500,000 $0.035$17,500
    13/09/2018Sue MacLeman142,814 $0.035$4,998
    05/07/2016Benjamin Yeo666,666 $0.030$20,000
    01/06/2016Benjamin Yeo100,000 $0.020$2,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Mark SimariChairman, Independent Director01/09/2016
    Glenn SmithManaging Director, CEO03/10/2017
    Jefferson HarcourtNon Exec Director26/02/2016
    Sue MacLemanDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Bruce HigginsChairman15/09/201710/05/2018
    Iain KirkwoodExecutive Chairman09/08/201030/10/2017
    Allan TanNon Exec Director01/12/201029/11/2016
    Benjamin YeoNon Exec Director26/02/201627/07/2016
    Bruce HewettNon Exec Director06/07/201012/07/2016
    Jonathan CoatesCEO12/07/201001/03/2015
    Jet SoedirdjaNon Exec Director12/07/201001/02/2012

    Date of first appointment, title may have changed.